Inventor
FOX DAVID JOHN
GB16 patents
⚠️ This page may combine multiple inventors who share the name “FOX DAVID JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CAMBRIDGE ENTPR LTD
6 patentsUS8008288B2Aug 30, 2011
Anti-inflammatory A-aminocyclolactam compounds
CAMBRIDGE ENTPR LTD2 citations62
US8008289B2Aug 30, 2011
α-aminocyclolactam ligands for G-protein coupled receptors
CAMBRIDGE ENTPR LTD2 citations62
US7897620B2Mar 1, 2011
Methods of using anti-inflammatory compounds
CAMBRIDGE ENTPR LTD4 citations62
US7803794B2Sep 28, 2010
Anti-inflammatory agents
CAMBRIDGE ENTPR LTD3 citations62
US7691845B2Apr 6, 2010
Anti-inflammatory agents
CAMBRIDGE ENTPR LTD2 citations62
US7662967B2Feb 16, 2010
Anti-inflammatory compounds and compositions
CAMBRIDGE ENTPR LTD4 citations62
GRAINGER DAVID J
5 patentsUS8497261B2Jul 30, 2013
3-aminocaprolactam compounds for treating inflammatory disorders
GRAINGER DAVID J0 citations50
US8389279B2Mar 5, 2013
α-aminocyclolactam ligands for G-protein coupled receptors, and methods of using same
GRAINGER DAVID J0 citations50
US8076323B2Dec 13, 2011
Anti-inflammatory agents
GRAINGER DAVID J1 citations50
US8063106B2Nov 22, 2011
ApoE mimetic agents
GRAINGER DAVID J0 citations50
US8618283B2Dec 31, 2013
Ligand libraries for screening GPCRs
GRAINGER DAVID J0 citations40
CENTESSA PHARMACEUTICALS UK LTD
4 patentsUS12221422B2Feb 11, 2025
Compounds and their use for the treatment of alpha1-antitrypsin deficiency
CENTESSA PHARMACEUTICALS UK LTD0 citations60
US12365672B2Jul 22, 2025
Compounds and their use for the treatment of alpha1-antitrypsin deficiency
CENTESSA PHARMACEUTICALS UK LTD0 citations57
US12291507B2May 6, 2025
Compounds and their use for the treatment of ALPHA1-antitrypsin deficiency
CENTESSA PHARMACEUTICALS UK LTD0 citations57
US12286402B2Apr 29, 2025
Compounds and their use for the treatment of alpha1-antitrypsin deficiency
CENTESSA PHARMACEUTICALS UK LTD0 citations57